3Feuring M, Christ M,Roell A,et al, Alterations in platelet function during the ovarian cycle[J], Blood Coagul Fibrinol,2002,13(5) :443.
4Chen CY, Lu CL. Delayed gastrointestinal transit in padents with hepatocellular carcinoma [J]. J Gastroenterol Hepatol,2002,17(12) :1254.
5Theodoridou S,Perifanis V.Elevated levels of serum vascular endothelial growth factor in patients with polycyth aemia vera[J].Acta Haematol,2003,110(1):16.
6Krishnamurti C,Stewart M.Assessment of omega-fattyacid-supplemented human platelets for potential improvement in long-term storage[J].Thromb Res,2002,105(2):139.
7Weibrich G,Kleis WK.Growth factor levels in plateletrich plasma and correlations with donor age,sex,andplatelet count[J].J Craniomaxillofac Surg,2002,30(2):97.
8Kuragano T,Kuno T.Comparison of the effects of cellulose triacetate and polysulfone membrane on GP Ⅱ b／Ⅲ a and platelet activation[J].Blood Purif,2003,21(2):176.
9Hourigan LA,Waiters DL.Heparin-induced thrombocytopenia:a common complication in cardiac transplant recipients[J].J Hear Lung Transplant,2002,21(12):1283.
10Hokari A,Zeniya M.Detcetion of serum nitrite and nitrate in primary biliary cirrhosis:possible role of nitric oxide in bile duct injury [J].J Gastroenterol Hepatol,2002,17(3):308.
